FORA Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

FORA Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,372	Closed	-$1.49M	–	545
2026 Q1	$1.49M	Buy	49,372 +4,946	+11%	+$159K	0.11%	186
2025 Q4	$1.39M	Buy	+44,426	New	+$1.09M	0.17%	150
2025 Q1	–	Sell	-106,078	Closed	-$2.34M	–	643
2024 Q4	$2.34M	Buy	+106,078	New	+$1.93M	0.27%	111
2022 Q2	–	Sell	-23,643	Closed	-$222K	–	678
2022 Q1	$222K	Buy	+23,643	New	+$197K	0.04%	466
2020 Q2	–	Sell	-125,001	Closed	-$1.12M	–	1299
2020 Q1	$1.12M	Buy	+125,001	New	+$1.28M	0.24%	105

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

FORA Capital's TEVA Position: Q2 2026 in Review

FORA Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 49,372 shares — an estimated $1.49M sold.

FORA Capital first reported a position in TEVA in Q1 2020 and held it in 5 quarters. The position peaked at $2.34M in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

FORA Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
FORA Capital sold 49,372 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.49M.
FORA Capital first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 5 quarters.
FORA Capital's Teva Pharmaceutical Industries Limited position peaked at $2.34M in Q4 2024.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.